163 related articles for article (PubMed ID: 15890923)
21. Time has come to include Human Papillomavirus (HPV) testing in sperm donor banks.
Depuydt CE; Donders G; Verstraete L; Vanden Broeck D; Beert J; Salembier G; Bosmans E; DhontT N; Van Der Auwera I; Vandenborne K; Ombelet W
Facts Views Vis Obgyn; 2018 Dec; 10(4):201-205. PubMed ID: 31367292
[TBL] [Abstract][Full Text] [Related]
22. Extracellular events impacting human papillomavirus infections: Epithelial wounding to cell signaling involved in virus entry.
Ozbun MA
Papillomavirus Res; 2019 Jun; 7():188-192. PubMed ID: 30981651
[TBL] [Abstract][Full Text] [Related]
23. Superinfection Exclusion between Two High-Risk Human Papillomavirus Types during a Coinfection.
Biryukov J; Meyers C
J Virol; 2018 Apr; 92(8):. PubMed ID: 29437958
[TBL] [Abstract][Full Text] [Related]
24. The Role of E6 Spliced Isoforms (E6*) in Human Papillomavirus-Induced Carcinogenesis.
Olmedo-Nieva L; Muñoz-Bello JO; Contreras-Paredes A; Lizano M
Viruses; 2018 Jan; 10(1):. PubMed ID: 29346309
[TBL] [Abstract][Full Text] [Related]
25. HPV disease transmission protection and control.
Christensen ND
Microb Cell; 2016 Sep; 3(9):476-490. PubMed ID: 28357382
[TBL] [Abstract][Full Text] [Related]
26. Human Papillomavirus (HPV) virion induced cancer and subfertility, two sides of the same coin.
Depuydt CE; Beert J; Bosmans E; Salembier G
Facts Views Vis Obgyn; 2016 Dec; 8(4):211-222. PubMed ID: 28210481
[TBL] [Abstract][Full Text] [Related]
27. The Cytoskeletal Adaptor Obscurin-Like 1 Interacts with the Human Papillomavirus 16 (HPV16) Capsid Protein L2 and Is Required for HPV16 Endocytosis.
Wüstenhagen E; Hampe L; Boukhallouk F; Schneider MA; Spoden GA; Negwer I; Koynov K; Kast WM; Florin L
J Virol; 2016 Dec; 90(23):10629-10641. PubMed ID: 27654294
[TBL] [Abstract][Full Text] [Related]
28. Herpes Simplex Virus 1 Enters Human Keratinocytes by a Nectin-1-Dependent, Rapid Plasma Membrane Fusion Pathway That Functions at Low Temperature.
Sayers CL; Elliott G
J Virol; 2016 Nov; 90(22):10379-10389. PubMed ID: 27630229
[TBL] [Abstract][Full Text] [Related]
29. Papillomavirus Infectious Pathways: A Comparison of Systems.
Biryukov J; Meyers C
Viruses; 2015 Aug; 7(8):4303-25. PubMed ID: 26247955
[TBL] [Abstract][Full Text] [Related]
30. Impact of inhibitors and L2 antibodies upon the infectivity of diverse alpha and beta human papillomavirus types.
Kwak K; Jiang R; Wang JW; Jagu S; Kirnbauer R; Roden RB
PLoS One; 2014; 9(5):e97232. PubMed ID: 24816794
[TBL] [Abstract][Full Text] [Related]
31. Potential anti-HPV and related cancer agents from marine resources: an overview.
Wang SX; Zhang XS; Guan HS; Wang W
Mar Drugs; 2014 Apr; 12(4):2019-35. PubMed ID: 24705500
[TBL] [Abstract][Full Text] [Related]
32. Concepts of papillomavirus entry into host cells.
Day PM; Schelhaas M
Curr Opin Virol; 2014 Feb; 4():24-31. PubMed ID: 24525291
[TBL] [Abstract][Full Text] [Related]
33. Identification of TRAPPC8 as a host factor required for human papillomavirus cell entry.
Ishii Y; Nakahara T; Kataoka M; Kusumoto-Matsuo R; Mori S; Takeuchi T; Kukimoto I
PLoS One; 2013; 8(11):e80297. PubMed ID: 24244674
[TBL] [Abstract][Full Text] [Related]
34. Differential dependence on host cell glycosaminoglycans for infection of epithelial cells by high-risk HPV types.
Cruz L; Meyers C
PLoS One; 2013; 8(7):e68379. PubMed ID: 23861898
[TBL] [Abstract][Full Text] [Related]
35. The papillomavirus major capsid protein L1.
Buck CB; Day PM; Trus BL
Virology; 2013 Oct; 445(1-2):169-74. PubMed ID: 23800545
[TBL] [Abstract][Full Text] [Related]
36. Principles of polyoma- and papillomavirus uncoating.
Cerqueira C; Schelhaas M
Med Microbiol Immunol; 2012 Nov; 201(4):427-36. PubMed ID: 23001401
[TBL] [Abstract][Full Text] [Related]
37. Use of an in vivo animal model for assessing the role of integrin α(6)β(4) and syndecan-1 in early steps in papillomavirus infection.
Huang HS; Lambert PF
Virology; 2012 Nov; 433(2):395-400. PubMed ID: 22995187
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of pneumonia virus of mice as a possible human pathogen.
Brock LG; Karron RA; Krempl CD; Collins PL; Buchholz UJ
J Virol; 2012 May; 86(10):5829-43. PubMed ID: 22438539
[TBL] [Abstract][Full Text] [Related]
39. Essential roles for soluble virion-associated heparan sulfonated proteoglycans and growth factors in human papillomavirus infections.
Surviladze Z; Dziduszko A; Ozbun MA
PLoS Pathog; 2012 Feb; 8(2):e1002519. PubMed ID: 22346752
[TBL] [Abstract][Full Text] [Related]
40. The cytoskeleton in papillomavirus infection.
Bienkowska-Haba M; Sapp M
Viruses; 2011 Mar; 3(3):260-271. PubMed ID: 21994730
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
